CALCIMIMETIC ADHERENCE AND PREFERENCE IN THE MANAGEMENT OF SECONDARY HYPERPARATHYROIDISM IN EUROPE: A PILOT STUDY

被引：0
|
作者：
Louie, Karly [1 ]
Nduka, Chidozie [1 ]
Taylor, Jo [2 ]
Hall, Matthew [3 ]
Aucella, Filippo [4 ]
Artero, Josep [5 ]
Na, Pablo Ure [6 ]
Labriola, Laura [7 ]
Andersson, Per-Olof [8 ]
Evenepoel, Pieter [9 ]
Oliva, Juan Carlos Gonzalez [10 ]
Pisoni, Ronald [11 ]
Fouqueray, Bruno [12 ]
Horne, Robert [13 ]
机构：
[1] AMGEN Ltd, Ctr Observat Res, Uxbridge, Middx, England
[2] Dorset Cty Hosp, Dorchester, England
[3] Nottingham Univ Hosp, Nottingham, England
[4] Fdn IRCCS Casa Sollievo Sofferenza, Nephrol & Dialysis Unit, San Giovanni Rotondo, Italy
[5] Hosp Univ Girona, Serv Nefrol, Girona, Spain
[6] Necker Enfant Malad Hosp, Serv Nephrol Dialyse, Paris, France
[7] Catholic Univ Louvain, Clin Univ St Luc, Dept Nephrol, Brussels, Belgium
[8] Vrinnevisjukhuset, Med Kliniken, Norrkoping, Sweden
[9] Univ Hosp Leuven, Div Nephrol, Leuven, Belgium
[10] Fdn Privada Hosp Mollet, Barcelona, Spain
[11] Arbor Res Collaborat Hlth, Ann Arbor, MI USA
[12] Amgen GmbH, Rotkreuz, Switzerland
[13] UCL, Sch Pharm, London, England
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2021年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
MO524
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Effects of a calcimimetic on the parathyroid glands of rats with chronic renal insufficiency and severe secondary hyperparathyroidism.
    Fox, J
    Chin, J
    Nemeth, EF
    Furuya, Y
    Ishii, H
    Wada, M
    Nagano, N
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A2670 - A2670
  • [42] EXPLORING THE POTENTIAL VALUE OF IMPROVED CARE FOR SECONDARY HYPERPARATHYROIDISM (SHPT) WITH A NOVEL INVESTIGATIONAL CALCIMIMETIC THERAPY
    Stollenwerk, B.
    Iannazzo, S.
    Cooper, K.
    Belozeroff, V
    VALUE IN HEALTH, 2016, 19 (07) : A519 - A519
  • [43] Calcimimetic NPS R-568 prevents parathyroid hyperplasia in rats with severe secondary hyperparathyroidism
    Wada, M
    Nagano, N
    Furuya, Y
    Chin, J
    Nemeth, EF
    Fox, J
    KIDNEY INTERNATIONAL, 2000, 57 (01) : 50 - 58
  • [44] Population Pharmacokinetics and Pharmacodynamics of the Calcimimetic Etelcalcetide in Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Hemodialysis
    Chen, P.
    Gisleskog, P. Olsson
    Perez-Ruixo, J. J.
    Xiao, J.
    Wilkins, J.
    Narayanan, A.
    Gibbs, J. P.
    Melhem, M.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2016, 5 (09): : 484 - 494
  • [45] Long-term effects of etelcalcetide as intravenous calcimimetic therapy in hemodialysis patients with secondary hyperparathyroidism
    Shigematsu, Takashi
    Fukagawa, Masafumi
    Yokoyama, Keitaro
    Akiba, Takashi
    Fujii, Akifumi
    Odani, Motoi
    Akizawa, Tadao
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2018, 22 (02) : 426 - 436
  • [46] The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease
    Quarles, LD
    Sherrard, DJ
    Adler, S
    Rosansky, SJ
    McCary, LC
    Liu, W
    Turner, SA
    Bushinsky, DA
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (03): : 575 - 583
  • [47] Current management of secondary hyperparathyroidism in Europe (COSMOS).: Differences between patients according to vintage
    Fernandez-Martin, J. L.
    Ketteler, M.
    London, G.
    Gorriz, J. L.
    Kramar, R.
    Martin, P. Y.
    Covic, A.
    Tielemans, C.
    Naves-Diaz, M.
    Teplan, V.
    Goldsmith, D.
    Locatelli, F.
    Cannata-Andia, J. B.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 362 - 362
  • [48] Etelcalcetide, A Novel Calcimimetic, Prevents Vascular Calcification in A Rat Model of Renal Insufficiency with Secondary Hyperparathyroidism
    Longchuan Yu
    James E. Tomlinson
    Shawn T. Alexander
    Kelly Hensley
    Chun-Ya Han
    Denise Dwyer
    Marina Stolina
    Charles Dean
    William G. Goodman
    William G. Richards
    Xiaodong Li
    Calcified Tissue International, 2017, 101 : 641 - 653
  • [49] Two-year treatment with the calcimimetic AMG 073 in hemodialysis patients with secondary hyperparathyroidism (SHPT).
    Moe, SM
    Sprague, SM
    Adler, S
    Rosansky, SJ
    Albizem, MB
    Blaisdell, PW
    Guo, MD
    Goodman, WG
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 572A - 572A
  • [50] Current Management of Secondary Hyperparathyroidism: a Multicenter Observational Study (COSMOS)
    Cannata-Andia, Jorge B.
    Luis Fernandez-Martin, Jose
    Zoccali, Carmine
    London, Gerard M.
    Locatelli, Francesco
    Ketteler, Markus
    Ferreira, Anibal
    Covic, Adrian
    Floege, Juergen
    Ketteller, Markus
    London, Gerard M.
    Locatelli, Francesco
    Luis Gorriz, Jose
    Rutkowski, Boleslaw
    Ferreira, Anibal
    Memmos, Dimitrios E.
    Verbeelen, Dierik
    Tiellemans, Christian
    Covic, Adrian
    Teplan, Vladimir
    Bos, Willem Jan
    Nagy, Judit
    Kramar, Reinhard
    Goldsmith, David J. A.
    Martin, Pierre-Yves
    Wuethrich, Rudolf P.
    Pavlovic, Drasko
    Benedik, Milhael
    JOURNAL OF NEPHROLOGY, 2008, 21 (03) : 290 - 298
12345